Gingival hyperplasia – an innovative method of treatment using Er:YAG and diode lasers

Katarzyna Świder, Jacek Matys, Rafał Flieger

Streszczenie

Hiperplazja dziąsła jest patologicznym stanem rozrostowym dziąsła, który może wystąpić u osób stosujących pewne leki, u pacjentów ze złą higieną jamy ustnej, a także towarzyszyć leczeniu ortodontycznym lub chorobie genetycznej.

Nieleczony stan ten może doprowadzić do zaburzeń wyrzynania się zębów, wad zębowych, akumulacji płytki nazębnej, pogorszenia funkcji żucia i mowy, złej estetyki i gorszego samopoczucia pacjenta. W leczeniu najpopularniejszą metodę stanowi gingiwektomia. W pracy przedstawiono przypadek pacjenta z hiperplazją okolicy zęba 23, u którego zastosowano metodę leczenia wykorzystującą lasery Er:YAG i diodowy.

Hasła indeksowe: hiperlazja dziąsła, rozrost dziąsła, laser Er:YAG, laser diodowy

 

Abstract

Gingival hyperplasia is a pathological condition of  proliferation of the gingiva that may occur in patients using certain medicines, in patients with bad oral hygiene, and also associated with orthodontic treatment or genetic disease.

If untreated this condition may lead to disturbances in tooth eruption, malocclusions, plaque accumulation, worsening of the chewing function and of speech, bad aesthetics and a generally worse feeling by the patient. The most popular method is gingivectomy. The study describes a case of a patient with hyperplasia in the region of tooth 23, in whom the treatment was with the use of Er:YAG and diode lasers.

Key words: gingival hyperplasia, gingival enlargement, Er:YAG laser, diode laser

PIŚMIENNICTWO

1. Sakamoto R. i wsp.: Histochemical, immunohistochemical and ultrastructural studies of gingival fibromatosis: A case report. Med. Electron Microsc.,  2002,  35, 248-254.

2. Kather J. i wsp.:  Clinical and histomorphometric characteristics of three different families with hereditary gingival fibromatosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2008,105, 348-352.

3. Kantarci A. i wsp.:  Apoptosis in gingival overgrowth tissues. J. Dent. Res., 2007, 86, 9), 888-892.

4. Bokenkamp A. i wsp.: Nifedipine aggravates cyclosporine A-induced hyperplasia. Pediatr. Nephrol., 1994,  8,  181-185.

5. Wong W. i wsp.: Resolution of cyclosporin-induced gingival hypertrophy with metronidazole. Lancet, 1994;, 343, 8903, 986.

6. Lafzi A., Farahani R.M.Z., Shoja M.A.M.: Phenobarbital-induced gingival hyperplasia. J. Contemp. Dent. Pract., 2007,  8, 6, 50-56.

7. Reynolds N.C. Jr, Kirkham D.B.: Therapeutic alternatives in phenytoin-induced gingival hyperplasia. A case report and discussion. J. Periodontol., 1980, 51, 9,  516-520.

8. Kavvadia K. i wsp.; Gingival fibromatosis and significant tooth eruption delay in an 11 year old male. A 30 month follows up. Int. J. Pediatr. Dent., 2005,  15, 294-302.

9. Hakkinen .L, Csiszar A.: Hereditary gingival fibromatosis: characteristics and novel putative pathogenic mechanism. J. Dent. Res., 2007, 86, 25-34.

10. Martelli-Júnior H. i wsp.:  Case report of a new syndrome associating gingival fibromatosis and dental abnormalities in a consanguineous family. J. Periodontol., 2008; 79, 7, 1287-1196.

11. Aldred M.J., Bartold P.M.: Genetic disorders of the gingivae and periodontium. Periodontol. 2000, 1998, 18,  7-20.

12. Pina-Neto J.M. i wsp.: Cherubism, gingival fibromatosis, epilepsy, and mental deficiency (Ramon syndrome) with juvenile rheumatoid arthritis. Am. J. Med. Gen., 1986, 25, 433-441.

13. Coletta R.D., Graner E.: Hereditary gingival fibromatosis: a systematic review. J. Periodontol., 2006, 77, 753-764.

14. Katsikeris N., Angelopoulos E., Angelopoulos A.P. : Peripheral giant cell granuloma: clinicopathological study of 224 new cases and review of 95 reported cases. Int. J. Oral and Maxillofac. Surg., 1988,17, 2), 94-99.

15. Vally I.M, Altini M.:  Fibromatoses of the oral and paraoral soft tissues and jaws. Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 1990, 69,191-198.

16.  Hou G.L., Tsai C.C.: Primary gingival enlargement as a diagnostic indicator in acute myelomonocytic leukemia. A case report. J/ Periodontol. ,1988, 59, 12, 852-855.

17. Casavecchia P. i wsp.: Hereditary gingival fibromatosis associated with generalized aggressive periodontitis. A case report. J. Periodontol., 2004,  75, 770-778.

18. Chaturvedi R.: Idiopathic gingival fibromatosis associated with generalized aggressive periodontitis: a case report. J. Can. Dent. Assoc., 2009, 75, 291-295.

19. Carranza F.A., Hogan E.L.: Carranza’s Clinical Periodontology – Gingival enlargement. W.B. Saunders Company, Philadelphia, Penn 2006, 373-390.

20. Jadhav T. i wsp.: Chronic inflammatory gingival enlargement associated with orthodontic therapy –  a case report. J. Dent. Hyg., 2013,  87, 1, 19-23.

21. Clocheret K. i wsp.: Idiopathic gingival hyperplasia and orthodontic treatment: a case report. J. Orthod., 2003, 30, 1), 13-19.

22. Omori K. i wsp:. Gingival overgrowth caused by vitamin C deficiency associated with metabolic syndrome and severe periodontal infection: a case report. Clin. Case Rep., 2014, 2, 6, 286-295.

23. Özkaya E., Babuna G.: Two cases with nickel-induced oral mucosal hyperplasia: a rare clinical form of allergic contact stomatitis? Dermatol. Online J., 2011,  17, 3, 12.

24. Kabashima K., Miyachi Y.: Gingival hyperplasia due to metal allergy. Clin. Exp. Dermatol., 2005, 30, 1), 88-89.

25. Doufexi A., Mina M., Ioannidou E.: Gingival overgrowth in children: epidemiology, pathogenesis, and complications: a literature review. J. Periodontol.,  2005,  76, 3-10.

26. Greenberg K.V., Armitage G.C., Shiboski C.H.: Gingival enlargement among renal transplant recipients inthe era of new-generation immunosuppressants. J. Periodontol., 2008, 79, 3,453-460.

27. Jucgla A. i wsp. The use of azithromycin for cyclosporin-induced gingival overgrowth. Br. J. Dermatol., 1998, 138, 1,  198-199.

28. Witkop C.J. Jr:  Heterogeneity in gingival fibromatosis. Birth Defects, 1971, 7, 7, 210-221.

29. Gama S.K.C. i wsp.:  Effectiveness of CO2 laser in removal of papillary gingival hyperplasia. Dental Press J. Orthod., 2012, 17, 2, 33e1-33e6.

30. Hoed-Petersen B.: The potential use of CO2 laser gingivectomy for phenytoin-induced gingival hyperplasia in mentally retarded patients. J. Clin. Periodontol., 1993, 20, 10, 729-731.

31. Dawes J.C. i wsp.: Electrosurgery in patients with pacemakers/implanted cardioverter defibrillators. Ann. Plast. Surg., 2006,  57, 1, 33-36.

32. Walsh L.J.: Erbium dental lasers and bone modification. Aust. Dent. Pract., 2008, Sept/Oct, 106-108.

33. Ishikawa I., Aoki A., Takasaki A.A.: Clinical application of erbium:YAG laser in periodontology. J. Int. Acad. Periodontol., 2008, 10, 1), 22-30.

34. Matys  J,  Dominiak  M.: Assessment  of  pain  during  uncovering  implants  with Er:YAG laser. Implantol. Stomatol.,  2014, 5, 2, 52-44.

35. Junji K., Wijeyeweera R.L.: The effect of CO2 lasers irradiation on oral soft issue problems in children in Sri Lanka. Photomed. Laser Surg., 2007, 25, 4, 264-268.

36. Kreisler M. i wsp.:   Effect of diode laser irradiation on root surfaces in vitro. J. Clin. Laser Med. Surg., 2002,  20, 2), 63-69.

37. Ize-Iyamu I.N., Saheeb B.D., Edetanlen B.E.: Comparing the 810 nm diode laser with conventional surgery in orthodontic soft tissue procedures. Ghana Med. J., 2013,  47, 3, 107-111.

38. Moritz A. i wsp.: Bacterial reduction in periodontal pockets through irradiation with a diode laser: a pilot study. J. Clin. Laser Med. Surg., 1997, 15, 1, 33-37.